- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 27/08 - Mydriatics or cycloplegics
Patent holdings for IPC class A61P 27/08
Total number of patents in this class: 31
10-year publication summary
|
0
|
0
|
0
|
1
|
3
|
6
|
5
|
5
|
2
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Opus Genetics, Inc. | 30 |
6 |
| Bodor Laboratories, Inc. | 59 |
2 |
| Brien Holden Vision Institute Limited | 85 |
2 |
| Abbott Laboratories | 2460 |
1 |
| Allergan, Inc. | 2434 |
1 |
| Abbott GmbH & Co. KG | 140 |
1 |
| Alcon, Inc. | 5183 |
1 |
| Daiichi Sankyo Company, Limited | 1872 |
1 |
| EyeGate Pharmaceuticals, Inc. | 10 |
1 |
| Nanyang Technological University | 1899 |
1 |
| Paragon BioTeck, Inc. | 13 |
1 |
| The Regents of the University of Colorado, a body corporate | 2534 |
1 |
| Rubicon Research Private Limited | 63 |
1 |
| Santen Pharmaceutical Co., Ltd. | 624 |
1 |
| Sentiss Pharma Private Limited | 25 |
1 |
| Unither Pharmaceuticals | 33 |
1 |
| Vitae Pharmaceuticals, Inc. | 97 |
1 |
| Singapore Health Services Pte Ltd | 458 |
1 |
| Warszawskie Zaklady Farmaceutyczne Polfa SA | 10 |
1 |
| Anhui Healstar Pharmaceutical Co., Ltd | 3 |
1 |
| Other owners | 4 |